Nancy Lurker has served as one of our directors since June 2011.
She has served as Chief Executive Officer and a director of PDI, Inc. since November 2008.
Prior to joining PDI, Ms. Lurker was Senior Vice President and Chief Marketing Officer of Novartis Pharmaceuticals Corporation, the US subsidiary of Novartis AG, where she oversaw a product portfolio in multiple therapeutic areas from June 2006 to December 2007.
Prior to that, she served as President and Chief Executive Officer of ImpactRx, Inc. since 2003.
From 2000 to 2003, Ms. Lurker served as Group Vice President-Global Primary Care Products for Pharmacia Corporation and as Global and US Vice-President for Detrol from 1998-2000 at Pharmacia.
From 1984 to 1998, Ms. Lurker rose from senior sales representative at Bristol Myer Squibb to various product management and business development positions, ultimately becoming Senior Director-Worldwide Cardiovascular Franchise Management of Bristol-Myers Squibb.
Ms. Lurker was a director of Elan Pharmaceuticals during 2005 and 2006 and of ConjuChem Biotechnologies Inc. from 2004 to 2006.
Ms. Lurker received a BS in Biology with high honors from Seattle Pacific University and an MBA from the University of Evansville.
more than 25 years of experience in the life sciences industry brings valuable commercial, operations and general management experience to the Board.
In addition, her
experience as a director of other publicly held life sciences companies brings further oversight and corporate governance experience to the Board.